Abstract:Rabies virus (RABV), the causative agent of rabies, is highly neurovirulent for warm-blooded animals with a mortality rate of up to 100%. The RABV matrix protein (M) is required for virus particle assembly and budding. However, little is known about antigenic differences in the M protein. In this study, five monoclonal antibodies (mAbs), designated 3B9, 4A1, 2B11, 2C1, and 4B11, against the RABV M protein were generated using a recombinant M protein. All five mAbs reacted with the CVS-11 strain but showed no reactivity against the HEP-Flury strain in indirect immunofluorescence and western blotting. The epitope targeted by these mAbs was further identified by peptide scanning using GST-fused peptides. The (PPYDDD30)-P-25 peptide was defined as the minimal linear epitope. Alignment of amino acid sequences and phylogenetic analysis of different RABV strains indicated that the variable epitope (25)PPDGDD(30) is only present in the HEP-Flury and variant Flury strains of clade III, while the other strains resembling ERA and SRVA9 within the clade had another variable epitope, (PLDDDD30)-P-25. A Y27D mutation within the epitope was found among the rest of the RABV strains distributed in different clades. However, a single D28G mutation eliminated the reactivity of these five mAbs. In addition, the mAbs were able to recognize wildtype RABV strain in indirect immunofluorescence and western blotting and detect RABV-infected brain tissue using immunohistochemistry. The newly established mAbs and identified epitope may facilitate future investigations in the structure and function of the M protein and the development of diagnostic methods for the detection of different RABV strains worldwide. Most importantly, the epitope recognized by the mAbs against M protein might serve as a novel target for the development of a vaccine targeting RABV virulent strains.

Preparation and identification of monoclonal antibody specific to the V region of rabies virus G protein

Cell Surface Display of Rabies Virus Glycoprotein by Using Ice Nucleation Protein

Preparation of Antibody against Rabies Virus and Development of ELISA Method for Determination of Rabies Virus Antigen

Generation Of Monoclonal Antibodies Against Variable Epitopes Of The M Protein Of Rabies Virus

Efficient generation of monoclonal antibodies against major structural proteins of rabies virus with suckling mouse brain antigen.

[Expression and purification of rabies virus glycoprotein and analysis of its specific binding capacity to memory B cells]

Prokaryotic Expression,Purification and Identification of Rabies Virus Glycoprotein Extracellular Domain Gene

Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein

Characterization of a human–mouse chimeric monoclonal antibody targeting rabies virus glycoprotein

Fine mapping and interaction analysis of a linear rabies virus neutralizing epitope.

Development of Human Monoclonal Antibodies With Broad Reactivity for Rabies Postexposure Prophylaxis

Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells

Prokaryoticexpression and Immunoreactivity Analysis of Rabies G Protein

Development of a novel bispecific antibody GR1801 for rabies

Novel Strategy for Expression and Characterization of Rabies Virus Glycoprotein

Preparation and Identification of Monoclonal Antibody Against Cytolysin of Vibrio Vulnificus

High-level Expression of Nucleoprotein Gene of Rabies Virus in Escherichia Coli

Immune-tolerizing procedure for preparation of monoclonal antibodies against glycoprotein E of Pseudorabies virus

Expression of Nucleoprotein of Rabies Virus in Bac-To-Bac/AcMNPV Baculovirus Expression System

High Level Expression of Rabies Virus Glycoprotein Extracellular Domain Gene in Escherichia Coli